| |
|
|
| |
| |
|
|
| |
 |
|
| |
| |
Title |
Patent No |
Brand /Ingredient |
| 01. |
Use of Piperine to increase bioavailability of nutritional compounds |
US 5,536,506 |
BioPerine® |
| 02. |
Use of Piperine as a bioavailability enhancer |
US 5,744,161 |
BioPerine® |
| 03. |
Potassium hydroxycitrate for the suppression of appetite and induction of weight loss |
US 5,783,603 |
Citrin®K |
| 04. |
Novel Method of preparing a Forskolin composition from Forskolin extract and use of Forskolin for promoting lean body mass and treating mood disorders |
US 5,804,596 |
ForsLean® |
| 05. |
Bioprotectant composition, method of use and extraction process of Curcuminoids |
US 5,861,415 |
Curcumin C3 Complex® |
| 06. |
Use of Piperine as a bioavailability enhancer |
US 5,972,382 |
BioPerine® |
| 07. |
Process for making high purity piperine for nutritional use |
US 6,054,585 |
BioPerine® |
| 08. |
Composition and method containing products extracted from Commiphora Wightii for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease |
US 6,436,991 B1 |
Gugulipid® |
| 09. |
Composition and methods containing an antimicrobial essential oil extracted from Coleus Forskohlii; antiacne |
US 6,607,712 |
Coleus Oil |
| 10. |
Cross regulin composition of turmeric-derived Tetrahydrocurcuminoids for skin lightening and protection against UVB rays |
US 6,653,327 |
Tetrahydrocurcuminoids |
| 11. |
Process of obtaining composition of stable lutein and lutein derivatives |
US 6,689,400 |
ZeaLutein® |
| 12. |
Process for the production of potassium hydroxy citric acid and compositions containing the potassium hydroxy citric acid |
US 6,770,782 |
Citrin® K
|
| 13. |
Manufacturing processes for Se-Methyl-L-Selenocysteine
|
US 6,794,537 |
MSC |
| 14. |
Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
US 6,849,645 |
Cosmoperine®(THP)
|
| 15. |
Process for preparing water soluble diterpenes and their applications; producing water solution of forskolin for pharmaceutical, nutraceutical or cosmetic use
|
US 6,960,300 |
Forskolin Water Soluble
|
| 16. |
Composition and methods containing bioavailable Se-methyl-L-Selenochysteine for human and veterinary use as a nutritional supplement |
US 6,982,273
|
MSC
|
| 17. |
A Convenient Process of Manufacture For Difluromethylornithine And Related Compounds
|
US 6,998,502 |
Difluromethylornithine
|
| 18. |
A Convenient Process of Manufacture For Difluromethylornithine And Related Compounds
|
US 7,345,196 B1 |
Difluromethylornithine |
| 19. |
Compositions and Methods containing Allium Sativum Linn, (Garlic) naturally enriched with organic selenium compounds for nutritional supplementation |
US 7,014,874 B1 |
GarliSelect®
|
| 20. |
Bioavailable compositions of Natural and Synthetic HCA
|
US 7,063,861
|
GarCitrin®
|
| 21. |
Compositions and methods containing natural compounds from non-conventional sources that are useful in maintaining normal blood sugar levels |
US 7,160,562 |
Flemingia macrophylla
|
| 22. |
Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts process for their manufacture and uses |
US 7,202,270 |
R-Lipoic Acid Water soluble Salts
|
| 23. |
Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails
|
US 7,217,546
|
Policosanol |
| 24. |
Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers
|
US 7,253,324
|
Resvenox™ & Oxyresvenox
|
| 25. |
Method of preparation and use of coconut water in mammalian tissue nourishment, growth, and healthy maintenance |
US 7,300,682 |
Cococin™
|
| 26. |
New Chemical entities with multiple modes of anti-inflammatory action
|
US 7,371,889
|
AKBBA
|
| 27. |
Chemical entities with multiple modes of anti-inflammatory action |
US 7,378,442 |
AKBBA |
| 28. |
Process for the Manufacture of Chiral And Racemic Forms of 3-Aminotetrahydrofurans, their Salts and Derivatives |
US 7,514,573 |
API Intermediates |
| 29. |
Non-cytotoxic synthetic analogues of (1E, 6E )-1,7-Bis (4 hydroxy-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione and therapeutic applications thereof in cystic fibrosis) |
US 7521580 |
Curcumin C3 Complex |
| 30. |
Composition and methods for the management of hyperproliferative dermatological conditions |
US 7582314 |
Boswellin® |
|
|
|
| |
|
|
| |
|
|
| |
 |
|
| |
| |
Title |
Patent No |
Brand /Ingredient |
| 01. |
Use of Piperine as a bioavailability enhancer |
EP0810868 |
BioPerine® |
| 02. |
Novel method of preparing a Forskolin composition from Forskolin extract and use of Forskolin for promoting lean body mass and treating mood disorders |
EP0977564 |
ForsLean® |
| 03. |
Bioprotectant composition, method of use and extraction process of Curcuminoids |
EP0839037 |
Curcumin C3 Complex® |
| 04. |
Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
GB2380675 |
Cosmoperine®
(THP) |
| 05. |
Bioavailable compositions of Natural and Synthetic HCA |
AU773081 |
GarCitrin® |
| 06. |
Bioavailable compositions of Natural and Synthetic HCA |
NZ518116 |
GarCitrin® |
| 07. |
Bioavailable compositions of Natural and Synthetic HCA |
EP1254209 |
GarCitrin® |
| 08. |
Coconut water and its method of preparation |
EP1341547 |
Cococin™ |
| 09. |
Use of Tetrahydrocurcuminoids to Regulate Physiological and Pathological Events in the Skin and Mucosa
|
EP1171144 |
Tetrahydrocurcuminoids |
| 10. |
Use of Piperine as a Bioavailability Enhancer |
JP3953513 |
BioPerine® |
| 11. |
Use of Piperine as a Bioavailability Enhancer |
CA2247467 |
BioPerine® |
| 12. |
Forskolin for promoting Lean Body Mass |
CA2281562 |
ForsLean® |
| 13. |
Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
|
JP4098985 |
Cosmoperine®
(THP) |
| 14. |
Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives |
NZ552997 |
Forskolin |
| 15. |
Process of preparing water soluble diterpenes and their applications |
SG121197 |
ForsLean® |
| 16. |
Process of preparing water soluble diterpenes and their applications |
MX260326 |
ForsLean® |
| 17. |
Bioavailable compositions of Natural and Synthetic HCA |
JP4205943 |
GarCitrin® |
| 18. |
Use of Tetrahydrocurcuminoids to Regulate Physiological and Pathological Events in the Skin and Mucosa |
AU2006235807 |
Tetrahydrocurcuminoids |
| 19. |
Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa |
NZ514884 |
Tetrahydrocurcuminoids |
| 20. |
Process of obtaining composition of stable lutein and lutein derivatives |
JP4227409 |
ZeaLutein® |
| 21. |
A method for solubilizing forskolin and a composition thereof |
IN235492 |
Forskolin Eye Drops |
| 22. |
A process for obtaining high purity fatty alcohols |
IN229695 |
Policosanol |
| 23. |
Compositions and methods for the management of hyperproliferative dermatological conditions |
RU2366412 |
Boswellin® |
| 24. |
Compositions and methods for the management of hyperproliferative dermatological conditions |
SG136165 |
Boswellin® |
| 25. |
Composition and methods for the management of hyperproliferative dermatological Conditions. |
ZA2007/0694 |
Boswellin® |
| 26. |
Process for preparing water soluble diterpenes and their applications |
ZA2006/01898 |
Forskolin Eye Drops |
| 27. |
Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |
|
Tetrahydrocurcuminoids |
|
|
|
| |
|
|
|
|
|
| |
|
|
| |
Note: |
|
|
